ITEMS IN AFP WITH KEYWORD:
An overview of the recent results from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) and implications for clinical practice and public health.
Decisions about cancer screening in older patients should be individualized, taking into account life expectancy, potential benefits vs. harms, and patient preferences. Get suggestions on how to incorporate current guidelines into daily practice.
Apr 15, 2016 Issue
Screening for Breast Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends biennial screening mammography for women aged 50 to 74 years.
Practical strategies can help family physicians and women in their 40s make more informed decisions about breast cancer screening.
The American Cancer Society (ACS) organized an interdisciplinary guideline development group to review the available evidence on breast cancer mortality, quality of life, life expectancy, false-positive findings, overdiagnosis, and overtreatment, and to update their 2003 guideline on breast cancer screening in average-risk women.
Before primary care physicians consider reintroducing the PSA test, they must have proof that it improves outcomes. The task will be to show in a future randomized study whether any PSA screening algorithm can improve survival or quality of life compared with what is now the standard of care—no routine screening.
Studies show no deaths were prevented and 1 in 5 underwent a prostate biopsy for a false-positive test. Read more.
Mar 15, 2015 Issue
Screening for Oral Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.
The U.S. Preventive Services Task Force (USPSTF) gave lung cancer screening a B recommendation on the basis of the reductions in disease-specific mortality and all-cause mortality seen in the National Lung Screening Trial (NLST). The NLST does not consider cost or cost-effectiveness in its recommend...
Jan 15, 2015 Issue
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women [Putting Prevention into Practice]
L.M. is a 37-year-old nonsmoking woman who is not taking any medications and has no significant past medical problems. Three of her female relatives have a history of breast cancer: her mother (diagnosed at 49 years of age, before menopause), her paternal grandmother (diagnosed at 72 years of age), ...